Abstract
The authors present five years results of the treatment of advanced carcinoma of the cervix uteri with 252Cf intracavitary therapy and increased dose of external beam radiation with hypoxyradiotherapy. The acute hypoxic state was achieved by inhalation of hypoxic gas mixture containing 8–8.5% oxygen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buchsbaum, H.J.(1979) Extrapelvic lymph node metastases in cervical carcinoma. Am. J. Obstet. Gynecol., 133:814–824
Bedford, J.S., Hall, E.G.(1963) Survival of He-la cells cultured in vitro and exposed to protracted gamma radiation. Int. J. Radiat. Biol. Oncol. Phys., 7:377–380
Bush, R.S., Jenkin, D.T., Allt, W.E.C., Bearle, F.A., Bean, H., Dembo, A.J., Pingle, J.F.: (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Brit J. Cancer, 37, suppl. III: 302–306.
Cohen, L: (1951) Estimation of biological dosage factors in clinical radiotherapy. Brit. J. Cancer, 5:180–194..
Drew, R.M., Fairchild, R.G., Atkins, H.L. (1972) The oxygen enhancement rations measured with He. La cells and protected irradiation from 252Cf and 137Cs. Radiology, 104:404–409.
Djordijevic, B., Anderson, L.L., Song Hie-Kim (1973) Oxygen enhancement rations in He-La cells irradiated with 252Cf and radium sources. Radiology, 107:429–433.
Delgaro, G., Caglar, H., Walker, P. (1978) Survival and complications in cervical carcinoma treated by pelvic field radiation after paraaortic lymphadenectomy. Am. J. Roentgoenol., 130:141–143.
Emanai, B., Watring, W.G., Won, Tak, Anderson, B., Piko, A.J. (1980) Para-aortic lymph node radiation in advanced cervical cancer. Int. J. Rad. Oncol. Biol. Phys., 6:1237–1241,.
Feola, J.M., Nava, C.A., Marzyama, Y. (1982) Biological effects of 252Cf neutrons at low dose rate. Int. J. Radiat. Biol., 41:33–46.
Fletcher, G.L., Lindberg, R.D., Caderao, J.B., Taylor, W.J.(1977) Hyperbaric oxygen as a radiotherapeutic adjuvant advanced carcinoma of the uterine cervix. Preliminary results of a randomized trial. Cancer, 39:617:623.
Gatemby, R.A., Coia, L.R., Richter, M.P., Katz, H., Moldfsky, P.J., Engstrom, P., Brown, D.Q., Brooklad, R., Broder, G.J. (1985) Oxygen tension in human tumors: In vivo mapping using Pt-guided probes. Radiology, 156:211–214.
Gragg R.L., Humphray, P.M., Thames, H.D., Jr., Meyn, R.E. (1978) The response of Chinese hamster ovary cells to fast neutron radiotherapy beams. III. Variation in relative biological effectiveness with position in the cell cycle. Rad. Res., 76: 283–289.
Hank, J.M. (1986) Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensiters. Int. J. Radiat. Oncol. Biol. Phys., 12:1339–1341.
Chism, A.E., Park, R.C., Keys, H.M. (1975) Prospects for para-aortic irradiation in treatment of cancer of the cervix. Cancer, 35:1505–1509.
Kapp, D.S., Fischer, D., Gutierrez, E., Kohorn, E.I., Schwartz, P.E. (1983) Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of effect of age, stage, histology and blood counts on survival. Int. J. Radiat. Oncol. Biol. Phys., 9:445–455.
Leibel, S., Bauer, M., Wasserman, T., Marcial, C., Rotman, M., Hornback, N., et al.: (1987) Radiotherapy with or without misonizadole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. Int. J. Radiat. Oncol. Biol. Phys., 13:541–549.
Maruyama, Y., Beach, J.L., Feola, J. (1980) Scheduling of hypoxic-tumor therapy using neutron brachytherapy. Radiology, 137:775–781.
Maruyama, Y., van Nagell, J.R., Yonada, J., Donaldson, E.S., Gallion, H.H., Powell, D., Kryscio, R.J. (1991) A review of Californium-252 neutron brachytherapy for cervical cancer. Cancer, 68: 1189–1197.
Maruyama, Y., van Nagell, J.R., Yonada, J., Donaldson, E.S. Gallion, H.H., Kryscio, R. (1991) 252Cf neutron brachytherapy treatment for cure of cervical cancer. Nuclear Science Applications, 4:181–192.
Maruyama, Y., Feola, J., Beach, J.L. (1983) A tumor/normal tissue advantage for low dose rate neutron brachytherapy. Int. J. Radiat. Oncol. Biol. Phys., 9:1715–1721.
Neumeister, K., Révész, L. (1987) Advances in hypoxiradiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 13:424–431.
Neumeister, K., Kamprad, F., Arnold, P., Jahns, J., Mehlhorn, G., Johansen, U., Koch, F., Bolck, M. (1977) Fundamentals for application for hypoxic hypoxia for optimizing radiotherapy based on animal tests. Radiobiological Research and Radiotherapy, Vol. II: 197–297, Vienna, IAEA.
Peeples, W.J. (1976) The occurrence of metastases outside the abdomen and retroperitoneal space in invasive carcinoma of the cervix. Gynecol. Oncol., 4:307–311,.
Rubin, P. (1965) Cancer of cervix stage III, J. Amer. Med. Assoc, 193:1101–1107.
Steel, G.G., Feacock, J.H. (1989) Why are some human tumors more radiosensitive than others? Radiother. And Oncol, 15:63–72.
Stehman, F.B., Bundy, B.N., Keys, H., Currie, J.L., Mortel, R., Creasman, W.T. (1988) A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am. J. Obstet. Gynecol., 159:87–94.
Siracká E., Siracký, J., Pappová, N., Révész, L. (1982) Vascularisation radiocurability in cancer of the uterine cervix. Neoplasma, 29:183–188.
Tačev, T., Vacek, A., Prokes, B., Rašovká, O., Ptáčková, B., Strnad, V., Kryštof, V: On the relationship of 252Cf and 226Ra radiation doses to the reoxygenation and regression of the cervix uteri tumour. Part I: Clinical eperimental study. This issue.
Tačev, T., Ptáčková,, B., Vacek, A., Rašovká, O., Prokeš, B., Strnad, V., Kryštof, V.: On the relationship of 252Cf and226 Ra radiation doses to the reoxygenation and regression of the cervix uteri tumour. Part II: Preliminary treatment results. This issue.
Vacek, A., Rotkovská, D., Bartoničková, A. Tačev, T. (1986) Differences in the radioprotective effects of hypoxic hypoxia in normal tissue and in experimental tumors. Int. J. Radiat. Biol., 49:858.
Vacek, A., Raková, A., Rotkovská, D., Semenov, L.F., Dikovenko, E.A., Zeytunyan, K.A., Fedorov, B.A. (1982) Role of the route of administration of the 5-methoxytryptamine in the protective effects. Strahlenther. 143:677–685.
Vecek, A., Raková, A., Rogozin, V.D. (1973) Protective effects of 5-hydroxytryptamine on the hemopoetic stem cells of mice. Strahlenther. 146: 104–114.
Vecek, A., Šikulová, J., Bartončiková, A. (1982) K voprosu o ponizenii radiozashtitnogo effekta gazovoj gipoksiji u životnych adaptirovanych k nedostatku kisloroda. Med. Radiol. 3:26–29.
Whiters, H.R., Mason, K., Reid, B.O., Dubravsky, N., Barkley, H.Z., Jr., Brown, B.W., Smathers, J.B. (974) Response of mouse intestine to neutrons and gamma rays in relation to dose fraction and division cycle. Cancer, 34:39–46.
Yarmonenko, S.P., Vainson, A.A., Bereznova, L. I., Krimker, V.M., Ovakimov, V.G., Petrosian, E.P., Shmakova, N.I. (1976) The selective protection of normal tissues by irradiation of tumor-bearing mice in hypoxic hypoxia. Radiat. Res., 67:447–458.
Yarmonenko, S.P. (1988) Radiobiology of humans and animals. Mir. Publisher, Moscow.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Tačev, T., Ptáčková, B., Vacek, A., Rašovská, O., Strnad, V. (1997). Californium-252 and Hypoxyradiotherapy in Treatment of Advanced Carcinoma of the Cervix Uteri. In: Wierzbicki, J.G. (eds) Californium-252 Isotope for 21st Century Radiotherapy. NATO ASI Series, vol 29. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5766-7_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-5766-7_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6433-0
Online ISBN: 978-94-011-5766-7
eBook Packages: Springer Book Archive